MICOM Data Sets
Below are some data sets that are available for use for researchers interested in our work. If you use these data, we ask that you please cite them using the citation provided along with the data set.
For more information about MICOM, please visit our website micom-insight.net.
For MICOM code, please visit our Github page.
We have the following classes of data currently available:
Respiratory Surveillance Cohort Data Sets
HIVE/CoVE Cohort Data Download Data
These data are combined across two Michigan cohort studies conducted by the Center for Respiratory Virus Research and Response (CRVRR): the Household Influenza Vaccine Effectiveness (HIVE) Study, and CoVE study. A brief description of each study is given below, and for more information on these cohorts and their data, please visit the CRVRR website. The data provided below are weekly samples combined across both cohorts, censored if the total samples taken that week is <10.
- The HIVE cohort is a longitudinal cohort of approximately 300 households with children in southeastern Michigan with year-round active surveillance of acute respiratory illness of any severity. Self- or parent-collected nasal swabs are tested for influenza, RSV, and SARS-CoV-2.
- The CoVE Study began as a CDC-funded study evaluating the effectiveness of COVID-19 vaccines against symptomatic and asymptomatic infection in Michigan residents. It is a fully remote study involving nasal swab self-collection during acute respiratory illness, with periods of weekly swab collection in prior seasons. Like the HIVE cohort, samples are tested for influenza, RSV, and SARS-CoV-2 upon receipt.
MFIVE Data Download Data
This CDC-funded study works in partnership with other national sites to conduct active surveillance of individuals with medically-attended acute respiratory illness (active since 2010). In collaboration with Dr. Ivana Vaughn of the Henry Ford Health System, the Center’s researchers work with ambulatory clinics across southeast Michigan to collect data on vaccine effectiveness against respiratory viruses. Along with the other sites in the network, they distribute and collect swabs and clinical data to monitor vaccine effectiveness, while evaluating the epidemiology, clinical characteristics, and risk factors for influenza and COVID-19 across the US. This study is part of the CDC’s US Flu VE Network. More information about the US Flu VE Network. The data provided below are biweekly samples, censored if the total samples taken for that period is <10. The last line of the file represents cumulative totals.
Infectious Disease Genomics Data
Since 2020, the Lauring laboratory has been performing genomic surveillance of respiratory viruses nationally and across the State of Michigan. In 2024, we brought these activities under the umbrella of the Michigan Infectious Disease Genomics Center, one of three NIAID-supported Genomic Centers of Infectious Diseases. We currently sample influenza viruses and SARS-CoV-2 specimens provided by testing laboratories at Michigan Medicine and Henry Ford Health System as well as through the other studies on this page. Our surveillance of influenza viruses is supported by the NIAID Centers for Respiratory Virus Surveillance and Response (CEIRR), and our surveillance of SARS-CoV-2 is supported by a contract from the CDC. Completed genomes are available through NCBI Genbank under the following bioprojects: PRJNA1015662 (SARS-CoV-2), PRJNA1019712 (Influenza A virus), PRJNA1023536 (Influenza B virus), PRJNA1079770 (Respiratory Syncytial Virus).
SARS-CoV-2 Download Data
Influenza Download Data
